Trixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, Suspension - 360 Swissmedic Key 68388003 Registration Holder AstraZeneca AG Name Trixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, Suspension Date of registration 24.11.2021 Introduction of Sequence 24.11.2021 ATC-Classification Formoterol, Glycopyrronium Bromide and Budesonide (R03AL11) Revision date WHO WHO-DDD Valid until 23.11.2026 Index Therapeuticus (BSV) 03.04.30. Show package size 360 Index Therapeuticus (Swissmedic) 03.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 184.77 Limitation Yes Limitation text
Deductible 10 % Consumer price 217.35 Feedback FB GTIN 7680683880033 Medication Code Synthetika Pharmacode Disponibility
Composition budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. Packungsbestandteile Source Data was imported : 04.06.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
